Gene Expression Changes in Human Tendinopathy
Author Information
Author(s): Scott A Jelinsky, Scott A Rodeo, Jian Li, Lawrence V Gulotta, Joanne M Archambault, Howard J Seeherman
Primary Institution: Pfizer Research and Hospital for Special Surgery
Hypothesis
Is there selective regulation of certain cytokines, matrix metalloproteinases, and protein kinases in human samples of tendinopathy compared with normal tendons?
Conclusion
The study identified pathways and genes that are differentially regulated in tendinopathy samples, contributing to the understanding of the disease and potential therapeutic targets.
Supporting Evidence
- 983 transcripts were identified with significantly different expression patterns in diseased tendons.
- Global pathway analysis suggested altered expression of extracellular matrix proteins.
- Histological evaluation showed increased cellular content and vasculature in diseased tendons.
Takeaway
This study looked at how genes change in people with tendon injuries compared to healthy tendons, helping us understand the problem better.
Methodology
Histological evaluation and molecular profiling were used to determine gene expression changes in patients undergoing surgery for chronic tendinopathy.
Potential Biases
The study population was heterogeneous with variations in age, gender, symptoms, and duration of disease.
Limitations
Control tendons were taken from the same joints as diseased tendons, which may affect gene expression profiles.
Participant Demographics
Patients included both elite and recreational athletes with various tendon injuries.
Statistical Information
P-Value
< 0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website